Citation Tools
PDFRegular and Young Investigator Award Abstracts
Biomarkers, Immune Monitoring and Novel Technologies
160 Circulating tumor DNA for measurable residual disease (MRD) detection in multiple myeloma patients undergoing CAR T-cell therapy
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 160 Circulating tumor DNA for measurable residual disease (MRD) detection in multiple myeloma patients undergoing CAR T-cell therapy